New COVID-19 Study | Exercise | Nutrition, Cancer Information Highlights, May 28, 2020

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI NCI COVID-19 in Cancer Patients Study   Learn about the NCI COVID-19 in Cancer Patients Study (NCCAPS), a natural history study of COVID-19 in people with cancer. The knowledge gained from this study will help doctors better manage treatment for people with cancer and COVID-19. For Women with Breast Cancer, Regular Exercise May Improve Survival   A new study adds to the body of research linking exercise and longer survival in some women with breast cancer. Read about how being physically active is one way that survivors can improve their health. Nutrition Label Updated   The Nutrition Facts label that is displayed on food packages has been updated for the first time in 20 years. Learn how the label has changed to reflect the latest science, including links between nutrition and disease. Video—Cancer and Other Illnesses during COVID-19: How young patients and families can cope If you missed the live broadcast, you can now watch the recording of our Facebook Live event. Listen to our panel of experts discuss ways young people with cancer or other serious illnesses and their families can cope with the added stress of the COVID-19 pandemic. FDA Approvals New Treatment for Metastatic Lung Cancer We've updated our drug summaries for nivolumab (Opdivo) and ipilimumab (Yervoy). The Food and Drug Administration (FDA) approved this drug combination as first-line therapy for certain adults with metastatic non-small cell lung cancer that has the PD-L1 protein. New Treatments for Prostate Cancer We've updated our drug summaries for olaparib (Lynparza) and rucaparib (Rubraca). FDA recently approved these drugs for treatment of adults with prostate cancer that has spread, has certain germline or somatic mutations, and has not responded to treatments that lower testosterone levels.   Also of Interest Expanded Information on Coronavirus and Cancer Many people with cancer have questions about coronavirus. This new web page presents information about COVID-19, including: what patients with cancer should know about the virus how the virus may affect their cancer care research studies for people with cancer and COVID-19 news about NCI's response to COVID-19 Types of Clinical Trials There are many types of clinical trials. Each type is designed to answer different research questions and will help researchers learn things that will help people in the future. Learn more about natural history studies and other types of trials. Contact Us for Help Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892